5 Results for "

Estrogen receptor α antagonist 1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Estrogen receptor α antagonist 1" in MCE Product Catalog:

Cat. No.: HY-150692
CAS No.: 2580941-45-1
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Estrogen receptor α antagonist 1 (compound 35) is a highly selective antagonist of estrogen receptor α, with IC50s of 0.02, 6.55 and 7.73 μM for estrogen receptor α, estrogen receptor β and MCF-7 cells, respectively. Estrogen receptor α antagonist 1 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-144137
CAS No.: 2751609-45-5
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Estrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4) .
loading...
    loading...
Cat. No.: HY-113960
CAS No.: 1072145-33-5
Purity:  99.71%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ERRα antagonist-1 (Compound A) is a selective and high affinity agonist for estrogen-related receptor α (ERRα). ERRα antagonist-1 inhibits interaction of ERRα with Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and PGC-1β, the IC50 values are 170 nM and 180 nM, respectively .
loading...
    loading...
Cat. No.: HY-144733
CAS No.: 2762423-09-4
Research Areas:  

Cancer

ERα antagonist 1 (Compound 19d) is a potent, selective, covalent estrogen receptor α (ERα) antagonist. ERα antagonist 1 induces apoptosis and cell cycle G0/G1 phase arrest in MCF-7 cells .
loading...
    loading...
Cat. No.: HY-170382
CAS No.: 2757498-74-9
Research Areas:  

Cancer

ER covalent antagonist-1 (Compound 39D) is the antagonist for estrogen receptor α (ERα). ER covalent antagonist-1 inhibits the proliferation of ERα-positive cell MCF-7 with an IC50 of 0.98 μM, arrests the cell cycle at G0/G1 phase, and induces apoptosis. ER covalent antagonist-1 exhibits antitumor efficacy in mouse model .
loading...
    loading...